Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2020 | Radiomics in the prediction of immunophenotypes in male breast cancer

Venkata Pradeep Babu • 6 May 2020
ESMO Breast 2020
Breast Cancer

Venkata Pradeep Babu, MBBS, MD, DNB, of the Rajiv Gandhi Cancer Institute, New Delhi, India, discusses how radiomics can be used to predict immunophenotypes in male breast cancer using clinical, pathological and genomic data collated to produce a machine learning algorithm. Radiomics is the practice of converting conventional imaging into highly minable data by extracting quantitative features. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Venkata Pradeep Babu

Correlation between CEA and TNM stage in CRC
3:31
Correlation between CEA and TNM stage in CRC
Venkata Pradeep Babu • 10 Jul 2020
COVID-19 management in India
3:59
COVID-19 management in India
Venkata Pradeep Babu • 10 Jul 2020
Role of radiomics in intrahepatic CCA clinical prognosis
4:40
Role of radiomics in intrahepatic CCA clinical prognosis
Venkata Pradeep Babu • 10 Jul 2020
Value of radiomics and AI in cancer treatment
4:18
Value of radiomics and AI in cancer treatment
Venkata Pradeep Babu • 12 May 2020

Related Videos

How will SARMs fit into the current breast cancer treatment paradigm?
1:14
How will SARMs fit into the current breast cancer treatment paradigm?
Rafael Grochot • 2 Jul 2026
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
1:35
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
Rafael Grochot • 2 Jul 2026
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals